Bailard, Inc. Meira G Tx Holdings PLC Transaction History

Bailard, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$13.42 - $23.38 $206,668 - $360,052	-15,400 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$12.78 - $23.74 $12,780 - $23,740	-1,000 Reduced 6.1%	15,400 $366,000
Q3 2021 Nov 15, 2021	SELL	$11.73 - $16.08 $22,287 - $30,551	-1,900 Reduced 10.38%	16,400 $216,000
Q2 2021 Aug 13, 2021	BUY	$12.85 - $16.2 $235,155 - $296,460	18,300 New	18,300 $284,000

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $292M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.